Highlander Capital Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Highlander Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $57,397 - $72,432	-100 Reduced 50.0%	100 $69,000
Q1 2022 May 09, 2022	BUY	$595.12 - $698.43 $29,756 - $34,921	50 Added 33.33%	200 $140,000
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $47,830 - $60,798	100 Added 200.0%	150 $72,000
Q4 2017 Feb 13, 2018	SELL	$358.63 - $469.95 $53,794 - $70,492	-150 Reduced 75.0%	50 $19,000
Q3 2017 Nov 15, 2017	BUY	$431.38 - $504.0 $86,276 - $100,800	200	200 $89,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Highlander Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Highlander Capital Management, LLC with notifications on news.